MARK L BAUM Insider Trading $HROW HARROW HEALTH, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK L BAUM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK L BAUM. MARK L BAUM is Chief Executive Officer in Imprimis Pharmaceuticals, Inc. ($IMMY) and Director in Ideal Power Inc. ($IPWR) and Director in Eton Pharmaceuticals, Inc. ($ETON).
MARK L BAUM in HARROW HEALTH, INC.
Trading Symbol: HROWIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK L BAUM: Chief Executive Officer
Holdings: 1,687,676 shares
Current Value: $3,949,162
Latest Transaction: Apr 27 2021
$HROW Market Capitalization: $29.16M
$HROW Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK L BAUM in HARROW HEALTH, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETON, HROW, IPWR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | M | 0.00 | 850,000 | 0 | 0 | |
Apr 27 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Payment of Exercise | F | 8.26 | 334,129 | 2,759,906 | 1,353,547 | 1.7 M to 1.4 M (-19.80 %) |
Apr 27 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Buy | M | 0.00 | 850,000 | 0 | 1,687,676 | 837.7 K to 1.7 M (+101.47 %) |
Feb 26 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | M | 0.00 | 200,000 | 0 | 850,000 | |
Feb 26 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Buy | M | 0.00 | 200,000 | 0 | 837,676 | 637.7 K to 837.7 K (+31.36 %) |
Feb 23 2021 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jun 08 2020 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 7.87 | 600,000 | 4,722,000 | 600,000 | |
Jun 08 2020 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | D | 7.87 | 600,000 | 4,722,000 | 0 | |
Jan 06 2020 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 0.00 | 88,000 | 0 | 88,000 | |
Jan 06 2020 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 7.30 | 217,500 | 1,587,750 | 217,500 | |
Nov 25 2019 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | X | 1.79 | 156,000 | 279,240 | 0 | |
Nov 25 2019 | HROW | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Buy | X | 1.79 | 156,000 | 279,240 | 598,126 | 442.1 K to 598.1 K (+35.28 %) |
Feb 21 2019 | IMMY | HARROW HEALTH, INC ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 6.30 | 150,000 | 945,000 | 150,000 | |
Jan 04 2018 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 1.73 | 150,000 | 259,500 | 150,000 | |
Feb 03 2017 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 2.23 | 160,000 | 356,800 | 160,000 | |
Dec 21 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
Dec 21 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | P | 1.79 | 156,000 | 279,240 | 156,000 | |
Dec 21 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Sell | D | 1.72 | 83,709 | 143,979 | 442,126 | 525.8 K to 442.1 K (-15.92 %) |
Dec 21 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Buy | M | 1.72 | 200,000 | 344,000 | 525,835 | 325.8 K to 525.8 K (+61.38 %) |
Dec 21 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Buy | P | 1.79 | 156,000 | 279,240 | 325,835 | 169.8 K to 325.8 K (+91.85 %) |
Apr 05 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 3.95 | 180,000 | 711,000 | 180,000 | |
Apr 26 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | D | 0.00 | 1,050,000 | 0 | 0 | |
Apr 26 2016 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 0.00 | 1,050,000 | 0 | 1,050,000 | |
Aug 05 2015 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | A | 7.87 | 600,000 | 4,722,000 | 600,000 | |
Jul 20 2012 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Option Exercise | C | 0.00 | 10 | 0 | 0 | |
Jul 20 2012 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Grant | A | 0.00 | 800,000 | 0 | 1,646,927 | 846.9 K to 1.6 M (+94.46 %) |
Jul 20 2012 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Buy | J | 0.00 | 846,927 | 0 | 846,927 | 0 to 846.9 K |
Jul 20 2012 | IMMY | Imprimis Pharmaceu ... | BAUM MARK L | Chief Executive Off ... | Buy | C | 0.00 | 7,498,500 | 0 | 15,738,545 | 8.2 M to 15.7 M (+91.00 %) |
Page: 1